We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+10%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$264B
AUM Growth
+$16.6B
(+6.7%)
Cap. Flow
-$3.28B
Cap. Flow
% of AUM
-1.24%
Top 10 Holdings %
Top 10 Hldgs %
18.75%
Holding
3,331
New
118
Increased
1,090
Reduced
1,840
Closed
95
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.03B |
| 2 |
Bristol-Myers Squibb
BMY
|
+$649M |
| 3 |
NVIDIA
NVDA
|
+$329M |
| 4 |
AT&T
T
|
+$316M |
| 5 |
Tesla
TSLA
|
+$313M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$474M |
| 2 |
CELG
Celgene Corp
CELG
|
+$421M |
| 3 |
Broadcom
AVGO
|
+$411M |
| 4 |
Netflix
NFLX
|
+$387M |
| 5 |
Apple
AAPL
|
+$372M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.51% |
| 2 | Financials | 14.64% |
| 3 | Healthcare | 13.3% |
| 4 | Consumer Discretionary | 10.29% |
| 5 | Communication Services | 9.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
Vishay Intertechnology
VSH
$5.43B
| $33.7M | 0.01% |
1,582,160
-69,493
| -4% | -$1.35M |
|
|
RETA
877
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $33.5M | 0.01% |
163,926
-10,239
| -6% | -$1.87M |
|
878
Hilton Grand Vacations
HGV
$3.55B
| $33.5M | 0.01% |
973,365
+578,588
| +147% | +$19.9M |
|
879
CONMED
CNMD
$1.47B
| $33.5M | 0.01% |
299,178
-8,497
| -3% | -$906K |
|
880
Nordson
NDSN
$17.3B
| $33.3M | 0.01% |
204,194
-15,429
| -7% | -$2.44M |
|
881
Olin
OLN
$2.12B
| $33.2M | 0.01% |
1,926,526
-116,367
| -6% | -$2.08M |
|
882
ONE Gas
OGS
$5.04B
| $33.1M | 0.01% |
353,364
-44,165
| -11% | -$4.04M |
|
883
Unum
UNM
$14.3B
| $32.9M | 0.01% |
1,127,998
-314,070
| -22% | -$9.13M |
|
884
Nuveen ESG Emerging Markets Equity ETF
NUEM
$384M
| $32.8M | 0.01% |
1,200,469
-199,986
| -14% | -$5.22M |
|
885
Marriott Vacations Worldwide
VAC
$4.25B
| $32.8M | 0.01% |
254,498
-2,039
| -0.8% | -$239K |
|
886
Generac Holdings
GNRC
$12.5B
| $32.8M | 0.01% |
325,639
-25,633
| -7% | -$2.39M |
|
887
Lennox International
LII
$15.2B
| $32.8M | 0.01% |
134,259
-6,023
| -4% | -$1.49M |
|
|
RP
888
DELISTED
RealPage, Inc.
RP
| $32.8M | 0.01% |
609,341
-41,348
| -6% | -$2.36M |
|
889
Ashland
ASH
$3.5B
| $32.6M | 0.01% |
426,207
-192,946
| -31% | -$14.6M |
|
890
Eastman Chemical
EMN
$8.42B
| $32.6M | 0.01% |
411,503
+48,479
| +13% | +$3.73M |
|
|
NVRO
891
DELISTED
NEVRO CORP.
NVRO
| $32.6M | 0.01% |
277,206
+68,069
| +33% | +$6.74M |
|
892
Wabtec
WAB
$49.3B
| $32.6M | 0.01% |
418,467
-14,902
| -3% | -$1.1M |
|
893
Paylocity
PCTY
$7.98B
| $32.5M | 0.01% |
268,978
-50,246
| -16% | -$5.5M |
|
894
Kennametal
KMT
$2.52B
| $32.5M | 0.01% |
880,731
+551,327
| +167% | +$18.5M |
|
895
EQT Corp
EQT
$32.3B
| $32.5M | 0.01% |
2,979,519
+130,157
| +5% | +$1.27M |
|
896
SEI Investments
SEIC
$12.6B
| $32.4M | 0.01% |
495,297
-5,893
| -1% | -$366K |
|
897
Cousins Properties
CUZ
$4.88B
| $32.4M | 0.01% |
787,074
-458,994
| -37% | -$18M |
|
898
Materion
MTRN
$6.04B
| $32.4M | 0.01% |
544,693
+8,832
| +2% | +$522K |
|
899
Upbound Group
UPBD
$1.16B
| $32.4M | 0.01% |
1,122,185
-76,118
| -6% | -$1.99M |
|
900
Enviri
NVRI
$620M
| $32.3M | 0.01% |
1,404,314
+345,313
| +33% | +$7.22M |
|
Similar funds
VFT
Nuveen's Q4 2019 Portfolio in Review
As of Q4 2019, Nuveen held 3,331 positions worth $264B, up 6.7% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Nuveen's Q4 2019 filing shows 118 new, 1,090 increased, 1,840 reduced and 95 closed positions. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B. The largest sale was Cisco, an estimated $474M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Nuveen's largest Q4 2019 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B.
- Nuveen added most to Bristol-Myers Squibb in Q4 2019, an estimated $649M increase.
- Nuveen's biggest Q4 2019 reduction was Cisco, cutting an estimated $474M.
- Nuveen fully exited Celgene Corp in Q4 2019, selling an estimated $421M.
- Nuveen's ten largest holdings make up 19% of its $264B portfolio in Q4 2019.
- Nuveen opened 118 new positions and closed 95 in Q4 2019.
- Nuveen's portfolio value rose 6.7% quarter-over-quarter to $264B.
Based on Nuveen's 13F filing for Q4 2019, filed 14 Feb 2020.